In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans.
Multiple isolates of Cryptococcus neoformans were tested to compare the in vitro activity of a new triazole, SCH56592, with those of amphotericin B, fluconazole, and itraconazole, MICs of each drug were determined, and minimum fungicidal concentrations of SCH56592 and amphotericin B were measured. M...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1996
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163438/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8843302/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.8.1910 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
